{
  "title": "US, UK approvals not a priority for Russia COVID-19 vaccine Sputnik V - Business Insider",
  "link": "https://news.google.com/__i/rss/rd/articles/CBMiZGh0dHBzOi8vd3d3LmJ1c2luZXNzaW5zaWRlci5jb20vdXMtdWstYXBwcm92YWwtbm90LXByaW9yaXR5LXJ1c3NpYS1jb3ZpZC0xOS12YWNjaW5lLXNwdXRuaWstdi0yMDIxLTLSAWhodHRwczovL3d3dy5idXNpbmVzc2luc2lkZXIuY29tL3VzLXVrLWFwcHJvdmFsLW5vdC1wcmlvcml0eS1ydXNzaWEtY292aWQtMTktdmFjY2luZS1zcHV0bmlrLXYtMjAyMS0yP2FtcA?oc=5",
  "pubDate": "Tue, 02 Feb 2021 19:43:10 GMT",
  "source": "Business Insider",
  "content": "<ol><li><a href=\"https://news.google.com/__i/rss/rd/articles/CBMiZGh0dHBzOi8vd3d3LmJ1c2luZXNzaW5zaWRlci5jb20vdXMtdWstYXBwcm92YWwtbm90LXByaW9yaXR5LXJ1c3NpYS1jb3ZpZC0xOS12YWNjaW5lLXNwdXRuaWstdi0yMDIxLTLSAWhodHRwczovL3d3dy5idXNpbmVzc2luc2lkZXIuY29tL3VzLXVrLWFwcHJvdmFsLW5vdC1wcmlvcml0eS1ydXNzaWEtY292aWQtMTktdmFjY2luZS1zcHV0bmlrLXYtMjAyMS0yP2FtcA?oc=5\" target=\"_blank\">US, UK approvals not a priority for Russia COVID-19 vaccine Sputnik V - Business Insider</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Business Insider</font></li><li><a href=\"https://news.google.com/__i/rss/rd/articles/CBMiTmh0dHBzOi8vd3d3LmNubi5jb20vMjAyMS8wMi8wMi9oZWFsdGgvcnVzc2lhLXNwdXRuaWstdi1waGFzZS0zLWludGwvaW5kZXguaHRtbNIBUmh0dHBzOi8vYW1wLmNubi5jb20vY25uLzIwMjEvMDIvMDIvaGVhbHRoL3J1c3NpYS1zcHV0bmlrLXYtcGhhc2UtMy1pbnRsL2luZGV4Lmh0bWw?oc=5\" target=\"_blank\">Russia's Sputnik V vaccine is 91.6% effective against symptomatic Covid-19, interim trial results suggest</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">CNN</font></li><li><a href=\"https://news.google.com/__i/rss/rd/articles/CBMiKGh0dHBzOi8vd3d3LmJiYy5jb20vbmV3cy9oZWFsdGgtNTU5MDA2MjLSASxodHRwczovL3d3dy5iYmMuY29tL25ld3MvYW1wL2hlYWx0aC01NTkwMDYyMg?oc=5\" target=\"_blank\">Russia's Sputnik V vaccine has 92% efficacy in trial</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">BBC News</font></li><li><a href=\"https://news.google.com/__i/rss/rd/articles/CBMidGh0dHBzOi8vYXBuZXdzLmNvbS9hcnRpY2xlL3BhbmRlbWljcy1jb3JvbmF2aXJ1cy1wYW5kZW1pYy1jaGluYS1hc2lhLXBhY2lmaWMtcnVzc2lhLTBiNjFmMWNmNTdlYWJkNmI4YzkyZWQ0N2M0Y2E4NDUx0gEA?oc=5\" target=\"_blank\">Study: Pandemic's cleaner air added heat to warming planet</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">The Associated Press</font></li><li><a href=\"https://news.google.com/__i/rss/rd/articles/CBMikgFodHRwczovL3d3dy5ucHIub3JnL3NlY3Rpb25zL2Nvcm9uYXZpcnVzLWxpdmUtdXBkYXRlcy8yMDIxLzAyLzAyLzk2MzE2NjY0OC9ydXNzaWFzLXNwdXRuaWstdmFjY2luZS1pcy1yZXBvcnRlZC10by1iZS05Mi1lZmZlY3RpdmUtYWdhaW5zdC1jb3ZpZC0xOdIBAA?oc=5\" target=\"_blank\">Russia's COVID-19 Vaccine Reported To Be 92% Effective : Coronavirus Updates</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">NPR</font></li><li><strong><a href=\"https://news.google.com/stories/CAAqOQgKIjNDQklTSURvSmMzUnZjbmt0TXpZd1NoTUtFUWphZ2Q3c2tZQU1FWHhFWEZRbERnb2FLQUFQAQ?oc=5\" target=\"_blank\">View Full Coverage on Google News</a></strong></li></ol>",
  "contentSnippet": "US, UK approvals not a priority for Russia COVID-19 vaccine Sputnik V - Business Insider  Business Insider\nRussia's Sputnik V vaccine is 91.6% effective against symptomatic Covid-19, interim trial results suggest  CNN\nRussia's Sputnik V vaccine has 92% efficacy in trial  BBC News\nStudy: Pandemic's cleaner air added heat to warming planet  The Associated Press\nRussia's COVID-19 Vaccine Reported To Be 92% Effective : Coronavirus Updates  NPR\nView Full Coverage on Google News",
  "guid": "544610796fccb2af334b05d45ae4fad5",
  "isoDate": "2021-02-02T19:43:10.000Z",
  "original_created_at": "2021-02-02T19:43:10.000Z",
  "created_at": "2021-02-02T22:51:24.396Z",
  "original_guid": "52781349568730",
  "id": "544610796fccb2af334b05d45ae4fad5",
  "tags": [
    "Business Insider"
  ],
  "image": "https://i.insider.com/60197a02ee136f00183a9c53?width=1200&format=jpeg",
  "localize": [
    {
      "locale": "zh",
      "title": "美国、英国批准不是俄罗斯COVID-19疫苗的优先事项 Sputnik V - Business Insider"
    },
    {
      "locale": "zh-Hant",
      "title": "美國、英國批准不是俄羅斯COVID-19疫苗的優先事項 Sputnik V - Business Insider"
    }
  ]
}